GLOW Blend (GHK-Cu + TB-500 + BPC-157)

Product Overview

The GLOW Blend embodies the principle that carefully selected peptide combinations achieve synergistic effects exceeding individual components. GHK-Cu influences approximately 31% of the human genome, resetting gene expression patterns to favor tissue repair. BPC-157 activates FAK-paxillin and VEGFR2-Akt-eNOS signaling cascades. TB-500 serves as the dominant G-actin sequestering protein, orchestrating cytoskeletal dynamics for cell migration and remodeling.

Mechanism of Action

The three peptides activate complementary pathways: GHK-Cu drives collagen synthesis via TGF-β pathway activation (collagen production increases 70% in 12 weeks at optimal concentrations). BPC-157 upregulates VEGFR2 expression for angiogenesis. TB-500 sequesters G-actin to enable cell motility. All three suppress NF-κB for coordinated anti-inflammatory modulation.

Key Benefits

Synergistic Collagen Synthesis — GHK-Cu activates TGF-β for collagen Types I and III production. Combined with BPC-157's vascular support and TB-500's cytoskeletal organization, newly synthesized collagen forms properly organized matrices rather than scar tissue.

Coordinated Angiogenesis — Multi-pathway vascular development: GHK-Cu upregulates VEGF/FGF-2, BPC-157 activates VEGFR2, and TB-500 mobilizes endothelial progenitor cells. Creates comprehensive vascular network formation.

Anti-Inflammatory Coordination — All three peptides suppress NF-κB through distinct mechanisms, creating a cellular environment favoring repair over continued immune activation.

Wound Healing Acceleration — Optimizes all phases of repair from hemostasis through tissue remodeling. GHK-Cu modulates metalloproteinases for dynamic matrix remodeling, preventing excessive scarring.

References

1. Pickart L, et al. GHK peptide as a natural modulator of multiple cellular pathways in skin regeneration. *BioMed Res Int.* 2015;2015:648108.
2. Li Y, et al. Peptides: emerging candidates for the prevention and treatment of skin senescence. *Int J Mol Sci.* 2025;26(2):564.
3. Sosne G, et al. Thymosin beta 4 promotes dermal wound repair in diabetic and aged mice. *Wound Repair Regen.* 2002;10(6):369–374.